SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 10 filers reported holding SINOVAC BIOTECH LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 13,787 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 13,787 | 0.0% | 0.00% | – |
| Q3 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q2 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q1 2021 | $55,000 | 0.0% | 13,787 | -38.4% | 0.00% | – |
| Q4 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q2 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q1 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q4 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q3 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q2 2019 | $55,000 | -61.8% | 22,374 | 0.0% | 0.00% | – |
| Q1 2019 | $144,000 | -7.1% | 22,374 | 0.0% | 0.00% | – |
| Q4 2018 | $155,000 | -8.8% | 22,374 | 0.0% | 0.00% | – |
| Q3 2018 | $170,000 | – | 22,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verity Asset Management, Inc. | 35,884 | $188,000 | 0.17% |
| Orbimed Advisors | 2,667,500 | $14,004,000 | 0.10% |
| Freedom Investment Management, Inc. | 157,295 | $826,000 | 0.08% |
| Pine River Capital Management L.P. | 1,095,041 | $5,749,000 | 0.06% |
| FIRST MANHATTAN CO. LLC. | 603,666 | $3,169,000 | 0.02% |
| FIL Ltd | 1,091,500 | $5,730,000 | 0.02% |
| Renaissance Technologies | 1,263,200 | $6,632,000 | 0.02% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 179,899 | $944,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 4,068,406 | $21,359,000 | 0.01% |
| ProShare Advisors LLC | 44,592 | $234,000 | 0.00% |